Physician-Rare Tumor Medical Oncologist

Ochsner Health-Ochsner MD AndersonCancer Center

Ochsner MD Anderson Cancer Center of Ochsner Health System in Louisiana, is actively recruiting additional BC/BE Rare Tumor Medical Oncologist to join our group in NEW ORLEANS, LA. Ochsner Health is an integrated healthcare system with more than 36,000 employees and over 4,600 employed and affiliated physicians in over 90 medical specialties and subspecialties. It operates 47 hospitals and more than 370 health and urgent care centers across Louisiana, Mississippi, Alabama, and the Gulf South.

Aside from inpatient and outpatient patient care responsibilities, candidates have the opportunity to participate in or develop clinical research studies, teach fellows and residents, and contribute to the development of the program. Candidates must be board certified or board eligible in hematology and oncology.

Position Highlights:

• Specialized expertise/interest in rare tumor types (which can include Cancer of unknown primary, Appendiceal cancer, Gastrointestinal stromal tumors, Sarcomas, Mesothelioma, Neuroendocrine tumors, Peritoneal Cancer, Salivary gland cancer, Melanoma, Testicular Cancer, Thyroid Cancer, and others)
• Supported by robust, collaborative multidisciplinary provider teams including surgical oncology subspecialties, radiation oncologists, medical oncologists, and advanced practitioners
• Dedicated clinical navigation team and support services including pharmacists (including pharmacogenomics), dieticians, psychologists, geneticists, social workers
• Dedicated subspecialty tumor boards including distinct molecular tumor board and weekly clinical trial tumor board
  • Next generation sequencing on all cases, cancer genomic testing, targeted therapies based on individual patient and tumor characteristics supported by strong precision medicine and molecular pathology programs.
• Academic track position with dedicated time for teaching, research, etc.
• Commitment to research: Identifying and overseeing clinical trials; testing new and innovative therapies. Strong research support including in-house bioinformatics, statistics, medical editing, and more. This includes research collaboration through the MD Anderson partnership.

Ochsner MD Anderson Cancer Center is the leading oncology program in the Gulf South Region. For over 75 years, we have been dedicated to cancer research and new cancer treatment developments, with more clinical trials than anywhere else in the region. In the past year, Ochsner MD Anderson has provided both personalized and state-of-the-art care to more than 45,000 patients. Our multi-disciplinary approach, advanced technologies, and focus on clinical research and our Center for Innovative Cancer Therapies (phase 1 program) define our approach to cancer care. Ochsner MD Anderson Cancer Center has a long standing Hematology Oncology Fellowship and will launch our Classical Hematology Fellowship in 2025. Subspecialty interest is encouraged but not required for all locations. More than $175M has been invested in our facilities and technology over the last 10 years, reflecting our commitment to leading cancer care in the region and beyond.